ERBB2 and cancer: A study of 79 patients with Stages I through IV endometrial cancer with various histologies found that the number of cancers with positive HER-2 staining was greater in tumors with ≤50% compared to ≥50% myometrial invasion and in patients with absence compared to presence of positive lymph nodes [42].